Invivyd Financials
| IVVD Stock | USD 1.57 0.00 0.00% |
Invivyd Balance Sheet Chart
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.0112 | 0.0174 |
|
| |||||
| Current Ratio | 1.77 | 1.87 |
|
|
The financial analysis of Invivyd is a critical element in measuring its lifeblood. Investors should carefully consider Invivyd's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Invivyd | Select Account or Indicator | Build AI portfolio with Invivyd Stock |
Understanding current and past Invivyd Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Invivyd's financial statements are interrelated, with each one affecting the others. For example, an increase in Invivyd's assets may result in an increase in income on the income statement.
Please note, the presentation of Invivyd's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Invivyd's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Invivyd's management manipulating its earnings.
Invivyd Stock Summary
Invivyd, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Invivyd, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. Invivyd operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US46187W1071 |
| Business Address | 1601 Trapelo Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | invivyd.com |
| Phone | 781 819 0080 |
| Currency | USD - US Dollar |
Invivyd Key Financial Ratios
| Return On Equity | -0.68 | ||||
| Profit Margin | (1.20) % | ||||
| Operating Margin | (0.84) % | ||||
| Price To Sales | 8.79 X | ||||
| Revenue | 25.38 M |
Invivyd Key Balance Sheet Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Total Assets | 620.1M | 383.2M | 229.2M | 129.5M | 116.6M | 110.7M | |
| Other Current Liab | 56.3M | 22.0M | 40.9M | 50.2M | 57.8M | 38.3M | |
| Net Debt | (542.2M) | (88.4M) | (198.5M) | (68.0M) | (78.3M) | (82.2M) | |
| Retained Earnings | (292.1M) | (533.4M) | (732.1M) | (902.0M) | (811.8M) | (771.2M) | |
| Accounts Payable | 5.8M | 1.5M | 8.0M | 10.4M | 12.0M | 7.4M | |
| Cash | 542.2M | 92.1M | 200.6M | 69.3M | 62.4M | 59.3M | |
| Other Current Assets | 25.1M | 4.5M | 23.3M | 20.2M | 23.2M | 16.6M | |
| Total Liab | 62.1M | 27.2M | 51.7M | 62.0M | 55.8M | 61.7M | |
| Net Invested Capital | 558.0M | 356.0M | 177.5M | 67.5M | 60.8M | 57.7M | |
| Total Current Assets | 616.7M | 376.9M | 224.9M | 100.7M | 90.6M | 86.1M | |
| Net Working Capital | 554.7M | 351.9M | 174.6M | 38.7M | 34.8M | 33.1M |
Invivyd Key Income Statement Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Operating Income | (226.9M) | (248.0M) | (212.8M) | (176.9M) | (159.2M) | (167.1M) | |
| Ebit | (219.4M) | (226.3M) | (207.8M) | (176.9M) | (159.2M) | (167.1M) | |
| Research Development | 182.9M | 179.2M | 158.7M | 137.3M | 157.8M | 168.2M | |
| Ebitda | (219.4M) | (225.8M) | (205.8M) | (173.8M) | (156.4M) | (164.2M) | |
| Income Before Tax | (226.8M) | (241.3M) | (198.6M) | (169.9M) | (152.9M) | (160.6M) | |
| Net Income | (226.8M) | (241.3M) | (198.6M) | (169.9M) | (152.9M) | (160.6M) |
Invivyd Key Cash Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 427.2M | (450.1M) | 108.6M | (131.3M) | (118.2M) | (112.3M) | |
| Free Cash Flow | (184.8M) | (221.7M) | (173.8M) | (170.6M) | (153.6M) | (161.2M) | |
| Other Non Cash Items | 1.5M | 15.4M | (1.1M) | 19.8M | 17.8M | 12.1M | |
| Net Income | (226.8M) | (241.3M) | (198.6M) | (169.9M) | (152.9M) | (160.6M) | |
| End Period Cash Flow | 542.2M | 92.1M | 200.6M | 69.3M | 62.4M | 59.3M |
Invivyd Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Invivyd's current stock value. Our valuation model uses many indicators to compare Invivyd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Invivyd competition to find correlations between indicators driving Invivyd's intrinsic value. More Info.Invivyd is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At present, Invivyd's Return On Equity is projected to drop slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Invivyd by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Most indicators from Invivyd's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Invivyd current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invivyd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Invivyd Stock refer to our How to Trade Invivyd Stock guide.At present, Invivyd's Enterprise Value Multiple is projected to increase slightly based on the last few years of reporting.
| 2023 | 2024 | 2025 | 2026 (projected) | Other Operating Expenses | 212.8M | 202.3M | 232.6M | 220.4M | Depreciation And Amortization | 2.0M | 3.1M | 2.8M | 2.7M |
Invivyd fundamental ratios Correlations
Click cells to compare fundamentals
Invivyd Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Invivyd fundamental ratios Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Total Assets | 620.1M | 383.2M | 229.2M | 129.5M | 116.6M | 110.7M | |
| Other Current Liab | 56.3M | 22.0M | 40.9M | 50.2M | 57.8M | 38.3M | |
| Net Debt | (542.2M) | (88.4M) | (198.5M) | (68.0M) | (78.3M) | (82.2M) | |
| Retained Earnings | (292.1M) | (533.4M) | (732.1M) | (902.0M) | (811.8M) | (771.2M) | |
| Accounts Payable | 5.8M | 1.5M | 8.0M | 10.4M | 12.0M | 7.4M | |
| Cash | 542.2M | 92.1M | 200.6M | 69.3M | 62.4M | 59.3M | |
| Other Current Assets | 25.1M | 4.5M | 23.3M | 20.2M | 23.2M | 16.6M | |
| Total Liab | 62.1M | 27.2M | 51.7M | 62.0M | 55.8M | 61.7M | |
| Net Invested Capital | 558.0M | 356.0M | 177.5M | 67.5M | 60.8M | 57.7M | |
| Total Current Assets | 616.7M | 376.9M | 224.9M | 100.7M | 90.6M | 86.1M | |
| Net Working Capital | 554.7M | 351.9M | 174.6M | 38.7M | 34.8M | 33.1M |
Today, most investors in Invivyd Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Invivyd's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Invivyd growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Invivyd February 16, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Invivyd help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Invivyd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Invivyd based on widely used predictive technical indicators. In general, we focus on analyzing Invivyd Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Invivyd's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.55 | |||
| Information Ratio | 0.0185 | |||
| Maximum Drawdown | 46.37 | |||
| Value At Risk | (7.07) | |||
| Potential Upside | 11.11 |
Complementary Tools for Invivyd Stock analysis
When running Invivyd's price analysis, check to measure Invivyd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invivyd is operating at the current time. Most of Invivyd's value examination focuses on studying past and present price action to predict the probability of Invivyd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invivyd's price. Additionally, you may evaluate how the addition of Invivyd to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |